Stevens Capital Management’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,603
Closed -$862K 734
2019
Q1
$862K Buy
+3,603
New +$864K 0.04% 420
2018
Q4
Sell
-8,503
Closed -$2.4M 796
2018
Q3
$2.4M Buy
8,503
+3,397
+67% +$995K 0.09% 267
2018
Q2
$1.5M Sell
5,106
-693
-12% -$189K 0.05% 370
2018
Q1
$1.46M Buy
+5,799
New +$1.36M 0.06% 343
2017
Q2
Sell
-1,337
Closed -$204K 945
2017
Q1
$204K Sell
1,337
-2,704
-67% -$395K 0.01% 767
2016
Q4
$595K Buy
+4,041
New +$585K 0.02% 537
2016
Q1
Sell
-4,718
Closed -$532K 994
2015
Q4
$532K Buy
4,718
+1,400
+42% +$155K 0.02% 551
2015
Q3
$363K Sell
3,318
-6,645
-67% -$711K 0.02% 634
2015
Q2
$953K Buy
9,963
+7,223
+264% +$675K 0.03% 439
2015
Q1
$255K Sell
2,740
-6,027
-69% -$527K 0.01% 794
2014
Q4
$718K Buy
8,767
+3,465
+65% +$266K 0.02% 496
2014
Q3
$340K Buy
+5,302
New +$325K 0.01% 692
2014
Q1
Sell
-6,641
Closed -$423K 1182
2013
Q4
$423K Buy
6,641
+353
+6% +$22.7K 0.01% 691
2013
Q3
$427K Buy
+6,288
New +$449K 0.01% 682

Other funds holding ICUI

Stevens Capital Management's ICUI Position: Q2 2019 in Review

Stevens Capital Management sold out of ICU Medical (ICUI) in Q2 2019, closing a stake of 3,603 shares — an estimated $862K sold.

Stevens Capital Management first reported a position in ICUI in Q3 2013 and held it in 14 quarters. The position peaked at $2.4M in Q3 2018. 270 funds tracked by Wall St. Rank hold ICUI as of Q2 2019.

  • Stevens Capital Management reported no remaining ICU Medical position as of Q2 2019 after selling out during the quarter.
  • Stevens Capital Management sold 3,603 ICU Medical shares in Q2 2019, an estimated $862K.
  • Stevens Capital Management first reported a position in ICU Medical in Q3 2013 and held it in 14 quarters.
  • Stevens Capital Management's ICU Medical position peaked at $2.4M in Q3 2018.
  • 270 funds tracked by Wall St. Rank held ICU Medical as of Q2 2019.

Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.